<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="abstract" dtd-version="1.0" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CC</journal-id>
<journal-id journal-id-type="nlm-ta">Cardiol Croat</journal-id>
<journal-title-group>
<journal-title>Cardiologia Croatica</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Cardiol. Croat.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1848-543X</issn>
<issn pub-type="epub">1848-5448</issn>
<publisher><publisher-name>Croatian Cardiac Society</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">CC_13(5-6)_184</article-id>
<article-id pub-id-type="doi">10.15836/ccar2018.184</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Extended Abstract</subject></subj-group>
</article-categories>
<title-group>
<article-title>Secondary mitral regurgitation according to gender</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7904-8899</contrib-id><name><surname>Per&#x010D;i&#x0107;</surname><given-names>Marko</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8664-3338</contrib-id><name><surname>Planini&#x0107;</surname><given-names>Zrinka</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5989-6495</contrib-id><name><surname>Pa&#x0161;ali&#x0107;</surname><given-names>Ante</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3189-8661</contrib-id><name><surname>Fri&#x0161;&#x010D;i&#x0107;</surname><given-names>Tea</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8502-7816</contrib-id><name><surname>Gulin</surname><given-names>Dario</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0555-6863</contrib-id><name><surname>Adrovi&#x0107;</surname><given-names>Leon</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9701-0253</contrib-id><name><surname>Be&#x0161;i&#x0107;</surname><given-names>Dijana</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4488-0559</contrib-id><name><surname>&#x0160;iki&#x0107;</surname><given-names>Jozica</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<aff id="aff1"><label>1</label><institution>University Hospital &#x201C;Sveti Duh&#x201D;</institution>, <addr-line>Zagreb</addr-line>, <country>Croatia</country></aff>
<aff id="aff2"><label>2</label><institution>University of Zagreb School of Medicine</institution>, <addr-line>Zagreb</addr-line>, <country>Croatia</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>ADDRESS FOR CORRESPONDENCE: Marko Per&#x010D;i&#x0107;, Klini&#x010D;ka bolnica &#x201E;Sveti Duh&#x201C;, Sv. Duh 64, HR-10000 Zagreb, Croatia. / Phone: +385-91-3712-531 / E-mail: <email xlink:href="markopercicmef@gmail.com">markopercicmef@gmail.com</email></corresp></author-notes>
<pub-date pub-type="epub-ppub"><month>06</month><year>2018</year></pub-date>
<volume>13</volume>
<issue>5-6</issue>
<fpage>184</fpage>
<lpage>184</lpage>
<history>
<date date-type="received"><day>24</day><month>04</month><year>2018</year></date><date date-type="accepted"><day>10</day><month>05</month><year>2018</year></date>
</history>
<permissions>
<copyright-year>2018</copyright-year>
<copyright-holder>Croatian Cardiac Society</copyright-holder>
</permissions>
<kwd-group kwd-group-type="author"><title>Keywords: </title><kwd>secondary mitral regurgitation</kwd><kwd>gender</kwd></kwd-group>
</article-meta>
</front>
<body>
<p><bold>Background</bold>: Mitral regurgitation (MR) represents the second most common valvular heart disease (VHD) (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>). It is classified as primary (organic) and secondary (functional) MR, with secondary being more frequent (<xref ref-type="bibr" rid="r2"><italic>2</italic></xref>). Secondary MR is usually result of dilatative cardiomyopathy, ischemic heart disease, postmyocarditis and similar (<xref ref-type="bibr" rid="r2"><italic>2</italic></xref>). Its prevalence is approximately 1.6% to 19.4%, and is associated with worse prognosis than primary (<xref ref-type="bibr" rid="r3"><italic>3</italic></xref>). The aim of our study was to investigate the incidence of secondary MR according to gender.</p>
<p><bold>Patients and Methods</bold>: Retrospective study was conducted to assess the relation between MR with other VHD. A total of 686 patients, with male predominance of 55%, were included in the study.</p>
<p><bold>Results</bold>: Among all patients with MR 167 (24.3%) had secondary MR. The main cause was left ventricular enlargement with mitral annular dilatation, counting for 96 (57.5% of secondary MR patients and 14.0% of all MR patients). Other causes of secondary MR included ischemic and postmyocarditis causes, with frequency of 64 (38.3% of secondary MR patients and 9.3% of all MR patients) and 7 (4% of secondary MR patients and 1% of all MR patients), respectively. According to gender distribution, 99 (59.3%) males and 68 (40.7%) females had secondary MR. Dilatative cardiomyopathy was the main cause of secondary MR in both men and women (60.6% and 52.9%). Ischemic MR was present in 36 (36.4%) men, 28 (41%) women, while postmyocarditis MR was observed in 3 (3%) of men and 4(5.8%).</p>
<p><bold>Conclusion</bold>: Secondary MR presents high proportion of all MR causes. Dilatative cardiomyopathy was most common cause of secondary MR, regardless of gender groups, with men more affected. Ischemic cause was slightly more common in women than men.</p>
</body>
<back>
<ref-list>
<title>LITERATURE</title>
<ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andell</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Martinsson</surname><given-names>A</given-names></name><name><surname>Andersson</surname><given-names>C</given-names></name><name><surname>Stagmo</surname><given-names>M</given-names></name><name><surname>Z&#x00F6;ller</surname><given-names>B</given-names></name><etal/></person-group> <article-title>Epidemiology of valvular heart disease in a Swedish nationwide hospital-based register study.</article-title> <source>Heart</source>. <year>2017</year> Nov;<volume>103</volume>(<issue>21</issue>):<fpage>1696</fpage>&#x2013;<lpage>703</lpage>. <pub-id pub-id-type="doi">10.1136/heartjnl-2016-310894</pub-id><pub-id pub-id-type="pmid">28432156</pub-id></mixed-citation></ref>
<ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okura</surname><given-names>H</given-names></name><name><surname>Kataoka</surname><given-names>T</given-names></name><name><surname>Yoshida</surname><given-names>K</given-names></name></person-group>. <article-title>Renin-angiotensin system inhibitors in patients with myocardial infarction and secondary mitral regurgitation.</article-title> <source>Heart</source>. <year>2016</year> May;<volume>102</volume>(<issue>9</issue>):<fpage>694</fpage>&#x2013;<lpage>700</lpage>. <pub-id pub-id-type="doi">10.1136/heartjnl-2015-308536</pub-id><pub-id pub-id-type="pmid">26864671</pub-id></mixed-citation></ref>
<ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agricola</surname><given-names>E</given-names></name><name><surname>Oppizzi</surname><given-names>M</given-names></name><name><surname>Pisani</surname><given-names>M</given-names></name><name><surname>Meris</surname><given-names>A</given-names></name><name><surname>Maisano</surname><given-names>F</given-names></name><name><surname>Margonato</surname><given-names>A</given-names></name></person-group>. <article-title>Ischemic mitral regurgitation: mechanisms and echocardiographic classification.</article-title> <source>Eur J Echocardiogr</source>. <year>2008</year> Mar;<volume>9</volume>(<issue>2</issue>):<fpage>207</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.euje.2007.03.034</pub-id><pub-id pub-id-type="pmid">17600766</pub-id></mixed-citation></ref>
</ref-list>
</back>
</article>
